More than 50 latent TB cases and three active infections prompt Riordan High School to halt in‑person classes and expand ...
Globally, there are more than 650,000 newly diagnosed cases of bladder cancer annually, with up to approximately 80% of these ...
Economic Survey 2025-26: India's pharma industry shifts to value-driven approach, focusing on generics, biosimilars, and ...
India’s pharmaceutical industry is shifting from a volume-driven to a value-driven approach, with greater emphasis on complex ...
We recently published 10 Stocks Breaking Records While Wall Street Bleeds. ImmunityBio Inc. (NASDAQ:IBRX) was one of the top ...
ImmunityBio shares were 36% higher, at $7.52, after the company said it recently held a Type B End-of-Phase meeting with the Food and Drug Administration regarding its supplemental Biologics License ...
Following discussions with the U.S. FDA, the Agency recommended that the Company submit additional information for its ...
Up to $100 million in additional loan proceeds provide additional financial flexibility to advance detalimogene development and commercialization for bladder cancer$25 million advanced at close of the ...
Saudi Arabia leads the way as the first country to grant conditional approval for Anktiva, a groundbreaking treatment for ...
Shares of ImmunityBio IBRX surged 17.4% after it announced a recent face-to-face meeting with senior FDA officials to align ...
Our Bureau, New Delhi Thursday, January 29, 2026, 16:15 Hrs [IST] ...
The poster presentation will include updated safety and efficacy data from approximately 25 six-month evaluable BCG-Unresponsive NMIBC patients in the ongoing Phase 2 ADVANCED-2 trial. ADVANCED-2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results